
Balancing Innovation with Security: Building Scalable Data Platforms That Protect Privacy
Interestingly Srinivasa's contributions have led to measurable business impact. By implementing robust access control models and column-level encryption, he helped reduce the risk of sensitive data exposure by 50%. Through automation of audit and compliance workflows using tools like Snowflake Time Travel and data lineage tracking, he cut compliance preparation time by 60%. Additionally, his reusable ingestion templates and secure development environments improved development velocity by 40%. Perhaps most impressively, he rearchitected the platform to handle three times the user load without compromising on data privacy or system performance.
His expertise spans multiple industry sectors where data sensitivity is paramount. For healthcare enterprises in Texas, Srinivasa helped design and build a HIPAA-compliant data platform that integrated real-time patient data with masked personally identifiable health information, maintaining audit readiness and scalability. In the financial services domain, he architected a data privacy hub that enabled banks to manage and share financial data across departments securely ensuring no personally identifiable information was leaked. In retail, he developed a consent-based customer data platform that filtered usage dynamically based on real-time consent inputs, integrating seamlessly with Snowflake Streams and external APIs.
These contributions were not just conceptual but quantifiably impactful. He reduced compliance preparation time by 60% and cut the risk of data exposure by 50% through integrated masking and role-based access. Time to deploy secure data pipelines dropped by 35%, and post-architecture improvements enabled three times more users to be onboarded securely. His improvements to workload management increased support for concurrent secure workloads by 45%, reinforcing both scale and trust.
Based on his vast expertise, Srinivasa shares thoughtful insights on the possible trajectory of future data security systems. He feels that the real innovation would be in smarter and safer usage of data, rather than merely making data pipelines faster. In his opinion, organizations thriving will have integrated security into their innovation processes from the very start, whereas the ones who look at it as a bolt-on feature will find it increasingly difficult to secure their scaling operations. He further observes the rise of context-aware security, where access privileges are dynamically set based on user behavior, location, and data sensitivity. Especially important in this day and age, Srinivasa is pushing for "privacy as a service," urging organizations to automate the privacy layers into their infrastructure, including encryption, enforcement of consent, and data masking. For teams operating in development, analytics, and compliance, he supports a unified, tiered access approach to governed datasets so as to promote collaboration without compromising on ethics or safety regarding data. Srinivasa Kalyan's work is a compelling case study in building platforms that are both resilient and revolutionary. His ability to marry compliance with innovation, privacy with performance, and governance with growth stands as a model for data leaders worldwide. In a digital age defined by both acceleration and accountability, his story offers a roadmap for how to move fast while still staying secure.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India.com
4 days ago
- India.com
Why Tech Must Prioritize Surgeon-Centric Design in 3D Surgical Platforms by Arjun Urs
Medicine and technology evolution of novel freedoms ushering in a disruption in surgical design and patient disposition is therefore believed to be an emancipatory force. This 3D surgical platform provides the surgeon with a detailed view of body structures relevant to the patient and surgical techniques performed with an appropriate degree of precision. There exist such digital or computerized tools that do not stand with real surgical decision-makers, i.e., the operating surgeons. Hence the operating platform technology for these complex and urgent surgeries must now change the philosophy on which it has been designed from being an engineering-centrist one to being a surgeon-need-centric one. It should now set surgical teams' needs, their cognitive workflows, and their feedback methods with utmost precedence, as these are clinically imperative and cannot be compromised. Ill-designed systems would obstruct smooth conduct of operations and thereby endanger clinical success, while well-designed platforms promote cooperation and rapid clinical decision-making towards superior healthcare delivery. Arjun Urs: Engineering Empathy into High Stakes Technology This gap between technology and surgical practice is what Arjun Urs makes it his perennial assignment to build over. From within, he is considered to be the founding engineer of Intuitive, and, also as architecting the 3D Models Platform, Urs transformed the way surgical teams interfaced with digital planning tools. Accordingly, immersing oneself in the perspective of the end-user rather than formally assessing a product in terms of functionality, Urs shadowed surgeons through their workflows and translated real-world frustrations into design features that actually matter. Currently, hospital staff and surgeons use this cloud-based system to effortlessly order and visualize those 3D anatomical models: the genuine patient-specific models. Some of the features implemented under Urs' direction include the aforesaid context-aware annotations, one-click ordering, and web/mobile interfaces. These functions are inherently tied to improvements in usability: with pre-op planning time cut down, internal requests for support visibly fell; and within a year's time, the platform was operating in hundreds of departments. From Prototype to Platform: Architecting for Clinical Impact He calmed the mind of his inner philosopher, distilled the very surgeon-centric conceptual ethos through his efforts into a HIPAA-compliant, multi-departments system. He integrated clinical metadata into the ordering workflow and in that capacity enhanced the usability of the system further by integrating it with AWS serverless infrastructure, thereby striving for a state of technical excellence. This created an extremely interactive platform for collaborative work which significantly improved model management coupled with instant access to CT, MRI, and segmentation data on desktops, tablets, and mobiles. A rather rare integration of strict backend engineering with front-end empathy was the driving force behind the great adoption and huge impact of the platform. Beyond this, Urs enhanced the UX, which stripped away the bulk of cognitive load, drastically cut down switch time between tools, and re-engineered the 3D model revision workflow to reduce average turn-around time from days to less than one. More importantly, surgeons reported feeling much more confident about proceeding with clarity and smoothly guided workflows when performing these complex cases. Solving Problems Others Didn't Know Existed Much of his success pivots on working on gaps that were always falling through the cracks. By means of WebGL and progressive model loading, he innovated and optimized low-power device accessibility so that even under-resourced hospitals could utilize this advanced visualization tool. He approached problems from the angle of bridging the communication gap between engineers and clinicians by facilitating multidisciplinary sessions that converted clinical dissatisfactions into improvements in design that could be acted upon. The recognition for the results can be seen in the greater platform adoption and rise in ever-increasing rate of successful completions of order. Looking Forward: Integration, Not Just Innovation He holds the view that the future of 3D surgical platforms is not merely about richer visuals but rather integration. 'The real innovation lies in enabling non-linear surgical thinking,' he says. 'Surgeons don't operate in a straight line from diagnosis to decision. They loop back, consult, annotate, and pivot. Bringing us into an era in which hospitals are set to digitize and personalize surgical care, the approach by Arjun Urs stands as a brilliant testament to what happens when the frontier of engineering meets empathetic design. Surgeon-centric technology basically translates to better clinical outcomes besides being a better user experience.


News18
4 days ago
- News18
Kalyan Jewellers Shares Fall 13% From Day's High Despite Strong Q1 Results: What Brokerage Firms Say?
Kalyan Jewellers reports robust revenue growth of 31% YoY, led by 18% SSSG growth in India. Shares of Kalyan Jewellers India Ltd, the Thrissur-headquartered jewellery company, tumbled nearly 9% on Friday, August 8, despite registering gains in three of the past four trading sessions. The stock opened higher at Rs 615.65 but soon reversed course to hit an intraday low of Rs 535, which is 9.46% lower than the previous close of Rs 590.95 and 13.14% down from the day's high of Rs 616. Global brokerage Citi has reiterated its 'Buy' rating on the stock and raised its price target to Rs 700, citing solid financial performance. Revenue rose 31% year-on-year, with same-store sales growth in India at 18%, in line with expectations. More notably, EBITDA and PBT surged 35% and 49% YoY, respectively — exceeding Citi's estimates by 9% and 14% — aided by improved operating leverage, a pilot project, and higher platinum and silver sales. In addition, the company is: 'We have started off the ongoing quarter well despite continuing volatility in gold prices and a higher base. We are upbeat about the upcoming festive season across the country and are gearing up for the launch of fresh collections and campaigns," said Ramesh Kalyanaraman, Executive Director, Kalyan Jewellers India. Of the nine analysts covering the stock, eight have a 'Buy' rating, while one has a 'Sell' recommendation. Brokerage JM Financial also gave a 'buy' call for the shares with a price target of Rs 700. In its note, the brokerage said, 'Kalyan reported robust revenue growth of 31% YoY, led by 18% SSSG growth in India. It added 10/1 Kalyan store in India/US and 8 Candere stores. India EBITDA was 10% above our estimates led by robust gross margins as (i) company implemented a pilot project of lean credit period to its vendors which resulted in higher margins/better RoCE and, (ii) inventory gains due to increase in prices of silver/platinum. Company is planning to launch new regional brands for every state to target the customers with regional taste and capture the pie from unorganised segment; 1st brand will be launched in CY25. It has temporarily paused the repayment of its debt obligation until release of its real estate collateral. Demand in Q2 remained until last week of June, post which the high base is optically leading to some YoY slowdown in growth, with growth again expected to pick in Q2 due to the festive season." Its steps towards lean credit policy is expected to drive profitability and improve RoCE, while the regional brand strategy is aimed at increasing the TAM; however, this would also lead an increase in the overall capital employed in the business. We largely maintain our EPS estimates as benefits of better margins gets negated by higher interest cost required for working capital requirement for the new pilot. Maintain BUY rating on the stock with an unchanged target price of INR 700, based on 45x June'27 EPS, JM Financial stated. Stay updated with all the latest news on the Stock Market, including market trends, Sensex and Nifty updates, top gainers and losers, and expert analysis. Get real-time insights, financial reports, and investment strategies—only on News18. view comments Location : New Delhi, India, India First Published: August 08, 2025, 11:43 IST News business » markets Kalyan Jewellers Shares Fall 13% From Day's High Despite Strong Q1 Results: What Brokerage Firms Say? Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


Economic Times
4 days ago
- Economic Times
Kalyan Jewellers shares fall over 9% but target prices go up to Rs 700
Shares of Kalyan Jewellers India on Friday fell 9.4% to the day's low of Rs 534.95 on BSE after the company reported 31% YoY growth in revenue, but gross margins for the India business contracted 60 bps YoY to 13.6% due to the rising mix from franchised stores. However, brokerages like Citi and Motilal see the stock rallying up to Rs 700. ADVERTISEMENT "We model 21%/17%/21% revenue/EBITDA/PAT CAGR over FY26–28E. We reiterate our BUY rating with a TP of INR 700," Motilal Oswal said, adding that it has largely maintained its EPS estimates for FY26 and FY27. Kalyan's management indicated that there is no pent-up demand likely to emerge from the recent moderation in gold prices, as weddings have not been postponed. Studded share remained stable at 30.2% in 1QFY26 vs 30.4% in 1QFY25. Studded revenue rose 30%. Despite a higher base and increasing FOCO saliency (~43% of India revenue), profitability surprised positively (EBITDA / PAT up 35% / 49% YoY), supported by procurement gains and operating leverage. Non-south now contributes 50% of India revenue, studded share held at ~30%, and Middle East mix improved. It retained aggressive rollout guidance (170 stores in FY26 – 90 Kalyan and 80 Candere) and has plans to launch regional brands during the year."With steady demand trends, despite elevated gold prices and an accelerating store rollout, we expect Kalyan's revenue momentum to remain strong. With RoCE at 21.8% and net debt/equity (ex-GML) near zero, the business remains well placed to drive capital-efficient scale," ICICI Securities maintained its FY26 guidance of 170 new showrooms (90 Kalyan + 80 Candere), largely via the FOCO model. "We largely maintain our estimates, modelling revenue / EBITDA / PAT CAGRs of 28% / 33% / 51% over FY25–FY27E. We maintain ADD with a DCF-based unchanged target price of INR 670. At our TP, the stock will trade at a multiple of 42x FY27E EPS. Key risks: delay in showroom expansion and potentially higher competitive intensity in core South India markets," ICICI said. (You can now subscribe to our ETMarkets WhatsApp channel)